PROFECTUS BIOSCIENCES, INC.
BALTIMORE, United States · Founded 2015 · $35.0M raised
- Headquarters
- BALTIMORE, Maryland
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2G
- Total Funding
- $35.0M
- Last Round
- $5.0M Series CJul 2009
About
Profectus BioSciences is a clinical-stage vaccine platform company developing novel vaccines for viral diseases including HIV, Ebola, Marburg, Nipah, and malaria, using a proprietary recombinant vesicular stomatitis virus (rVSV) vector platform. The company has received significant NIH and CEPI contracts totaling over $80M to advance biodefense and infectious disease vaccines.
Summary
PROFECTUS BIOSCIENCES, INC. is a Biotech company based in BALTIMORE, United States, founded in 2015. It has raised $35.0M in total, most recently a $5.0M Series C round in Jul 2009.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...